Daniel White
Surgical · Westfield, NJNPI 1124603758
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.8%), education and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 45.2% of the total. Reporting peaked in 2022 at $4,145 and has fallen 57.6% since, to $1,759 in 2025. Among surgical clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $72.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Stryker$2K
- Seapearl East, Inc$789
- Johnson & Johnson$404
- Globus Medical$187
- Si-bone, Inc.$97
- plus $180 from 5 others
What the payments were for
- Travel & lodging$1,52020%
- Food & beverage$3,58748%
- Education$2,40032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 26 | $3,396 |
| Stryker | 62 | $2,454 |
| Seapearl East, Inc | 3 | $789 |
| Johnson & Johnson | 2 | $404 |
| Globus Medical | 4 | $187 |
| Si-bone, Inc. | 2 | $97 |
| Davol Inc. | 1 | $90 |
| BD | 1 | $36 |
| Heraeus Medical, LLC. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,507 in reported general payments places this provider in the 95th percentile of 462 surgical providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 46 | $1,260 |
| Pantoprazole Sodium | 25 | $298 |
| Meloxicam | 87 | $255 |
| Ondansetron OdtOndansetron | 13 | $204 |
| Cefadroxil | 28 | $108 |
| Tramadol Hcl | 41 | $100 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $96 |
| Oxycodone Hcl | 27 | $93 |
| Ondansetron Hcl | 14 | $65 |
Paid to pharmacies, not to this prescriber.
Other surgical in Westfield
- Matthew PetridesNeptune$183K
- Andrea ConwayCherry Hill$105K
- Dean BaroneUnion$69K
- Jessica HendersonEatontown$53K
- Richard BengelCamden$44K
- Dylan RyanCamden$26K
- Lauren RoyceClifton$11K
- Rachel WintMount Laurel$10K
- Richard HulseNeptune$10K
- Mimi OliffWest Orange$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.